Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs13279341 | chr8:140990881 | G/A | 6.29E-7 | 173 | 27.33 | 18.6 | 10.93 | KM Plot |
PCPG | rs13336131 | chr16:1697025 | C/T | 0 | 176 | 25.47 | 19.3 | 2.93 | KM Plot |
PCPG | rs13336178 | chr16:1667071 | C/T | 0 | 176 | 25.53 | 22.77 | 2.93 | KM Plot |
PCPG | rs13336753 | chr16:89595261 | T/C | 0.000303 | 177 | 28.58 | 25.53 | 19.2 | KM Plot |
PCPG | rs13383583 | chr2:209978497 | G/A | 5.41E-8 | 176 | 20.03 | 23.53 | 27.27 | KM Plot |
PCPG | rs13388304 | chr2:236192847 | C/T | 3.43E-7 | 171 | 26.58 | 24.7 | 3.07 | KM Plot |
PCPG | rs13389663 | chr2:176132982 | T/G | 0.000138 | 175 | 25.4 | 28.38 | 6.62 | KM Plot |
PCPG | rs13393069 | chr2:24324591 | C/T | 0.000122 | 176 | 25.47 | 26.92 | 17.43 | KM Plot |
PCPG | rs13393394 | chr2:242516498 | C/A | 4.19E-11 | 178 | 25.87 | 24.85 | 10.3 | KM Plot |
PCPG | rs13394881 | chr2:176196474 | A/T | 0.000124 | 177 | 25.28 | 28.47 | 6.62 | KM Plot |
PCPG | rs13403998 | chr2:242560241 | C/T | 3.41E-5 | 174 | 24.53 | 28.42 | 20.2 | KM Plot |
PCPG | rs13404054 | chr2:24297751 | C/T | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs13408129 | chr2:24316723 | G/A | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs13408226 | chr2:24316777 | G/A | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs13409729 | chr2:24325501 | A/G | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |